Form 4 Adaptive Biotechnologies For: Aug 05 Filed by: SOOD NITIN
Adaptive Biotechnologies Corporation (ADPT)
Last adaptive biotechnologies corporation earnings: 2/26 04:05 pm
Check Earnings Report
US:NASDAQ Investor Relations:
adhc.com
Company Research
Source: SEC EDGAR
Impact Snapshot
Event Time:
ADPT
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ADPT alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ADPT alerts
High impacting Adaptive Biotechnologies Corporation news events
Weekly update
A roundup of the hottest topics
ADPT
News
- Adaptive Biotechnologies Corporation (ADPT) Q2 2022 Earnings Call Transcript [The Motley Fool]The Motley Fool
- Adaptive Biotechnologies Corporation (ADPT) CEO Chad Robins on Q2 2022 Results - Earnings Call Transcript [Seeking Alpha]Seeking Alpha
- Adaptive Biotechnologies Reports Second Quarter 2022 Financial ResultsGlobeNewswire
- Adaptive Biotechnologies Receives Expanded Medicare Coverage of clonoSEQ® for Monitoring Minimal Residual Disease in Diffuse Large B-Cell LymphomaGlobeNewswire
- Adaptive Biotechnologies to Report Second Quarter of 2022 Financial Results on August 3, 2022GlobeNewswire
ADPT
Earnings
- 8/3/22 - Beat
ADPT
Sec Filings
- 8/3/22 - Form 10-Q
- 8/3/22 - Form 8-K
- 7/8/22 - Form 4
- ADPT's page on the SEC website